European Union

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month

What leaked US trade talks tell us about future of UK pharma IP
19 Nov 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 Nov 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

Latest

View all
13 Nov 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options Read more

12 Nov 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016 Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

5 Nov 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds Read more

Refine content by:

Designs

View all
25 Sep 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month Read more

3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

12 Oct 2017

Effective use of Community design protection

Design protection has taken on an increasingly important role in recent years, since appearance and exterior shape now play a fundamental role in the success of a product. Designs are now relevant to a wide range of products involving industry,… Read more

Finance

View all
22 Jun 2018

Qualcomm, France Brevets and IP Europe join forces to create a new funding initiative for European SMEs

A new financing and advisory mechanism to help innovative European SMEs secure high-quality patents and build effective portfolios will be rolled out across Europe in 2019, it was revealed today. The creation of Patent Factory Europe (PFE) was… Read more

FRAND/SEPS

View all
12 Jun 2019

Group including Ericsson Nokia, InterDigital and Qualcomm releases SEP licence negotiation principles

Move designed to influence debate in Europe and comes on same day as implementers publish their own guidelines.   Read more

14 May 2019

Why it's time for Europe to move beyond 5G's tired developers v implementers patent narrative

With European Parliament elections next week, and a new Commission in the Autumn, it is vital that policymakers are allowed to focus on what is really important: finding ways to build a true European digital innovation ecosystem Read more

3 Apr 2019

IAM’s Auto IP series taking place against a backdrop of major change

With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month Read more

9 Nov 2018

SEP owners must beware of hindering Europe's golden 5G opportunity

In an exclusive opinion piece for IAM, Jim Beveridge of the Innovators' Network argues that originators need to embrace transparency and avoid royalty stacking to allow IoT innovation to thrive  Read more

Law & Policy

View all
2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

29 Oct 2019

Four key IP implications from the rise of orphan drugs

The growing importance of rare disease treatments has strategic, commercial and potential political ramifications for life sciences IP Read more

25 Sep 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month Read more

24 Sep 2019

Latest CJEU developments will disappoint those seeking SPC clarity

Europe’s highest court has refused to tackle a long-standing question relating to third-party marketing approval, while its Advocate General has provided confusing guidance on Article 3(a) Read more

Litigation

View all
2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

25 Sep 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month Read more

24 Sep 2019

Latest CJEU developments will disappoint those seeking SPC clarity

Europe’s highest court has refused to tackle a long-standing question relating to third-party marketing approval, while its Advocate General has provided confusing guidance on Article 3(a) Read more

3 Sep 2019

Irish Supreme Court decision opens door to interlocutory injunctions

The more flexible test looks set to end the run of adverse decisions that have affected rights holders in one of Europe’s key life sciences hubs Read more

Market Developments

View all
2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

29 Oct 2019

Four key IP implications from the rise of orphan drugs

The growing importance of rare disease treatments has strategic, commercial and potential political ramifications for life sciences IP Read more

24 Sep 2019

Latest CJEU developments will disappoint those seeking SPC clarity

Europe’s highest court has refused to tackle a long-standing question relating to third-party marketing approval, while its Advocate General has provided confusing guidance on Article 3(a) Read more

26 Aug 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last Read more

Non practising entities

View all
5 Aug 2018

NPEs like Sisvel have survived the storm - that's another reason why the deals market is picking up

A series of recent deals from Italian licensing business show that some patent owners are prospering in current climate.  Read more

7 Jun 2018

Two separate Sisvel deals with Samsung push the firm ever-closer to the big leagues

Sisvel has announced two deals with Samsung that confirm the IP mangement and licensing platform’s continued progress into the top division of the patent monetisation space. Not only has the Korean giant agreed to take a royalty-bearing licence to a… Read more

29 May 2018

German pharma patent troll claims EPC loophole paves a path to gold

A company described as a new-style European patent troll has told IAM that it believes a deal with a large pharma company is likely at some point this year. The organisation, which has used a provision in the European Patent Convention to make… Read more

20 Feb 2018

Despite the spin, new report shows NPEs are responsible for a fraction of European patent litigation

For several years executives from various US-based NPEs have been talking about the much more appealing litigation environment in various European countries as they have seen the climate become far tougher in their home market. Germany, in… Read more

Patent pools

View all
14 May 2019

Why it's time for Europe to move beyond 5G's tired developers v implementers patent narrative

With European Parliament elections next week, and a new Commission in the Autumn, it is vital that policymakers are allowed to focus on what is really important: finding ways to build a true European digital innovation ecosystem Read more

9 Nov 2018

SEP owners must beware of hindering Europe's golden 5G opportunity

In an exclusive opinion piece for IAM, Jim Beveridge of the Innovators' Network argues that originators need to embrace transparency and avoid royalty stacking to allow IoT innovation to thrive  Read more

Strategy

View all
24 Sep 2019

Latest CJEU developments will disappoint those seeking SPC clarity

Europe’s highest court has refused to tackle a long-standing question relating to third-party marketing approval, while its Advocate General has provided confusing guidance on Article 3(a) Read more

3 Sep 2019

Irish Supreme Court decision opens door to interlocutory injunctions

The more flexible test looks set to end the run of adverse decisions that have affected rights holders in one of Europe’s key life sciences hubs Read more

26 Aug 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last Read more

3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

Technology licensing

View all
29 Oct 2019

Four key IP implications from the rise of orphan drugs

The growing importance of rare disease treatments has strategic, commercial and potential political ramifications for life sciences IP Read more

26 Aug 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last Read more

20 Jun 2019

US tells WTO to hit pause on China IP complaint

Suspension of the probe may not herald a broader deal, but it does underscore the significant legislative concessions China has made on tech transfer and other IP issues Read more

12 Jun 2019

Group including Ericsson Nokia, InterDigital and Qualcomm releases SEP licence negotiation principles

Move designed to influence debate in Europe and comes on same day as implementers publish their own guidelines.   Read more

Trademarks

View all
12 Oct 2017

There'll be no easy bedding-in for António Campinos at the EPO; he'll have to hit the ground running

The news that António Campinos has been chosen to succeed Benoît Battistelli as president of the European Patent Office should not have come as a huge surprise to IAM’s readers. We predicted it might happen back in July. But the speed of the… Read more

12 Sep 2017

Preparing for Brexit - analysis of the European Commission's position paper on key IP issues

Last week the European Commission published a Brexit position paper on dealing with intellectual property issues raised by the UK’s departure from the European Union – which is scheduled to happen at the end of March 2019. The paper focused on… Read more

Trade secrets

View all
3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

20 Jun 2019

US tells WTO to hit pause on China IP complaint

Suspension of the probe may not herald a broader deal, but it does underscore the significant legislative concessions China has made on tech transfer and other IP issues Read more

3 Apr 2019

IAM’s Auto IP series taking place against a backdrop of major change

With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month Read more

29 Mar 2018

Trade secrets take centre stage

Political rhetoric has thrust trade secrets misappropriation into the spotlight. New legislation around the world means that rights holders have never had more options for enforcing their rights. Read more

Valuation

View all
26 Aug 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last Read more

Find an expert